- Issuer
- T. Rowe Price
- Inception Date
- Dec 29, 1995
- Category
- Health & Biotech Equities
- Index Tracked
- No Index (Active)
- Distribution Policy
- Distributing
- Asset Class
- Equity
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
THISX Performance Chart
T. Rowe Price Health Sciences Fund Class I (THISX) is up 8.7% since the beginning of the year. THISX is currently trading at $91 per share. Investors who bought $1,000 worth of THISX shares 5 years ago would now be looking at an investment worth $1,380.
Loading charts...
Compare this symbol against anything
Returns By Period
T. Rowe Price Health Sciences Fund Class I (THISX) has returned 8.73% so far this year and 33.49% over the past 12 months.
T. Rowe Price Health Sciences Fund Class I
- 1D
- -0.35%
- 1M
- -1.26%
- 6M
- 9.79%
- YTD
- 8.73%
- 1Y
- 33.49%
- 3Y*
- 15.21%
- 5Y*
- 6.65%
- 10Y*
- —
- ALL TIME*
- 14.23%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
THISX Monthly Returns History
Based on dividend-adjusted daily data since Jan 3, 2017, THISX's average daily return is +0.06%, while the average monthly return is +1.23%. At this rate, an investment would double in approximately 4.7 years.
Historically, 59% of months were positive and 41% were negative. The best month was Apr 2020 with a return of +13.9%, while the worst month was Jan 2022 at -12.4%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.
On a daily basis, THISX closed higher 53% of trading days. The best single day was Dec 16, 2024 with a return of +14.5%, while the worst single day was Mar 16, 2020 at -11.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.97% | 0.65% | -5.90% | 1.62% | 3.55% | 8.76% | 1.29% | 8.73% | |||||
| 2025 | 6.22% | -1.82% | -4.11% | -0.06% | -6.49% | 3.99% | -1.29% | 4.17% | 2.16% | 7.85% | 9.09% | -1.82% | 17.92% |
| 2024 | 2.04% | 4.08% | 1.67% | -4.96% | 2.32% | 2.85% | 2.69% | 5.21% | -1.95% | -4.99% | 1.50% | 5.81% | 16.75% |
| 2023 | 0.59% | -4.68% | 1.93% | 3.57% | -2.92% | 2.91% | -0.13% | -1.50% | -3.85% | -3.87% | 5.58% | 6.28% | 3.17% |
| 2022 | -12.38% | -0.37% | 4.75% | -8.56% | -0.89% | -0.55% | 5.60% | -3.09% | -4.25% | 7.70% | 4.18% | -3.00% | -12.11% |
| 2021 | 2.35% | -1.80% | -0.75% | 4.95% | -0.90% | 5.61% | 2.04% | 4.17% | -4.66% | 4.22% | -4.89% | 3.23% | 13.62% |
Benchmark Metrics
T. Rowe Price Health Sciences Fund Class I has an annualized alpha of 3.55%, beta of 0.83, and R2 of 0.58 versus S&P 500 Index. Calculated based on daily prices since January 03, 2017.
- This fund participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.06%) than losses (78.65%) - typical of diversified or defensive assets.
- This fund generated an annualized alpha of 3.55% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.
- Alpha
- 3.55%
- Beta
- 0.83
- R²
- 0.58
- Upside Capture
- 86.06%
- Downside Capture
- 78.65%
Expense Ratio
THISX has an expense ratio of 0.67%, placing it in the medium range.
Return for Risk
Risk / Return Rank
THISX ranks 72 for risk / return — above 72% of mutual funds peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund Class I (THISX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| THISX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.55 | ||
| Sortino ratioReturn per unit of downside risk | +0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.25 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 2.52 | 2.00 | +0.51 |
| Martin ratioReturn relative to average drawdown | 7.04 | 8.49 | -1.45 |
Dividends
Dividend History
T. Rowe Price Health Sciences Fund Class I provided a 11.27% dividend yield over the last twelve months, with an annual payout of $10.26 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $10.26 | $10.26 | $20.80 | $4.58 | $1.59 | $7.93 | $7.17 | $10.24 | $4.49 | $5.31 |
Dividend yield | 11.27% | 12.25% | 26.10% | 5.20% | 1.76% | 7.62% | 7.25% | 12.58% | 6.70% | 7.55% |
Monthly Dividends
The table displays the monthly dividend distributions for T. Rowe Price Health Sciences Fund Class I. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.26 | $10.26 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20.80 | $20.80 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.58 | $4.58 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.59 | $1.59 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.93 | $7.93 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the T. Rowe Price Health Sciences Fund Class I. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the T. Rowe Price Health Sciences Fund Class I was 28.97%, occurring on Mar 23, 2020. Recovery took 39 trading sessions.
The current T. Rowe Price Health Sciences Fund Class I drawdown is 2.22%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-28.97%Mar 2020 | 1mo 2d | 1mo 26d | 2mo 28dFeb 2020 - May 2020 | COVID crash2020 |
-27.53%Jun 2022 | 9mo 16d | 2y 2mo | 2y 11moSep 2021 - Aug 2024 | Bear market2022 |
-21.81%Dec 2018 | 2mo 24d | 6mo 11d | 9mo 5dOct 2018 - Jul 2019 | Rate-hike selloffLate 2018 |
-15.80%Apr 2025 | 2mo 1d | 6mo 15d | 8mo 16dFeb 2025 - Oct 2025 | 2025 selloff2025 |
-12.78%Mar 2026 | 2mo 3d | 3mo | 5mo 3dJan 2026 - Jun 2026 | — |
Drawdown Indicators
| THISX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.97% | -56.78% | +27.81% |
Max Drawdown (1Y)Largest decline over 1 year | -12.78% | -9.10% | -3.68% |
Max Drawdown (3Y)Largest decline over 3 years | -15.80% | -18.90% | +3.10% |
Max Drawdown (5Y)Largest decline over 5 years | -27.53% | -25.43% | -2.10% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -2.22% | -1.58% | -0.64% |
Average DrawdownAverage peak-to-trough decline | -7.10% | -10.70% | +3.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.56% | 2.14% | +2.42% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with THISX
Add T. Rowe Price Health Sciences Fund Class I to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with THISX